Post by gMendel

A Mayo Clinic study involving 484 seemingly healthy participants found that 13% carried severe, previously hidden genomic risks associated with conditions such as hereditary cancers and cardiovascular disorders. Surprisingly, while nearly all participants (98.6%) had at least one genetic finding requiring monitoring, fewer than half received appropriate follow-up care. This highlights that although genomic risk identification has become increasingly feasible, healthcare systems still face significant challenges in turning these insights into effective preventive action. To address this gap, Mayo Clinic launched “Precure,” an initiative aimed at predicting and detecting diseases years before clinical symptoms appear. Powered by advanced technologies, the initiative identifies microscopic changes in genes, molecules, and proteins, integrating them with genomic data. The program currently focuses on five major organ systems to better understand and predict the progression of conditions such as Alzheimer’s disease, heart failure, and chronic liver disease. These findings highlight the critical importance of early screening, as timely intervention leads to better patient outcomes, lower healthcare costs, and, ultimately, saved lives. 👉 https://lnkd.in/eb2JbiAM #NewbornScreening #HealthTech #Genomics #Genetics #RareDiseases #geneticdisorders #screening #diagnostics #healthcare #innovation #Growth #AI #artificialintelligence #machinelearning #VC #venturecapital Mayo Clinic Konstantinos Lazaridis Jessa Bidwell, MS, CGC